| 000 | 01401 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250511223304.0 | ||
| 264 | 0 | _c19901106 | |
| 008 | 199011s 0 0 eng d | ||
| 022 | _a8750-2836 | ||
| 024 | 7 |
_a10.1080/21548331.1990.11704115 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGoldstein, E J | |
| 245 | 0 | 0 |
_aCefoxitin in the treatment of aerobic and anaerobic infections. Prospective correlation of in vitro susceptibility methods with clinical outcome. _h[electronic resource] |
| 260 |
_bHospital practice (Office ed.) _cOct 1990 |
||
| 300 |
_a38-45 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBacteria, Aerobic _xdrug effects |
| 650 | 0 | 4 |
_aBacteria, Anaerobic _xdrug effects |
| 650 | 0 | 4 |
_aBacterial Infections _xdrug therapy |
| 650 | 0 | 4 |
_aCefoxitin _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMicrobial Sensitivity Tests _xmethods |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOutcome and Process Assessment, Health Care |
| 700 | 1 | _aCitron, D M | |
| 700 | 1 | _aCole, R E | |
| 700 | 1 | _aRangel, D M | |
| 700 | 1 | _aSeid, A S | |
| 700 | 1 | _aOstovari, M O | |
| 773 | 0 |
_tHospital practice (Office ed.) _gvol. 25 Suppl 4 _gp. 38-45 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/21548331.1990.11704115 _zAvailable from publisher's website |
| 999 |
_c2126420 _d2126420 |
||